Search Results for: covid-19

Useful Flexibilities for Animal Care and Use Programs to Comply with the PHS Policy During the COVID-19 Pandemic

As we continue to address the effects of COVID-19 and as some states and institutions are considering reopening, we would like to share some administrative flexibilities that NIH is providing to research institutions with laboratory animal programs. These flexibilities are meant to assure personnel safety and animal welfare while enabling research personnel to prioritize and preserve research efforts. Some of these can be useful in reducing administrative burden, too.

NIH-Wide Strategic Plan for COVID-19 Research Now Available

The NIH-Wide COVID-19 Strategic Plan, released on July 13, 2020, provides a framework describing how NIH is accelerating the development of therapeutic interventions, vaccines, and diagnostics in response to the SARS-CoV-2 global pandemic. It describes how NIH is rapidly mobilizing the biomedical research community, such as through establishing new programs that leverage existing resources, to lead a swift, coordinated research response.

Accepting Preliminary Data as Post-Submission Material and Other COVID-19-Related Application Flexibilities

As our nation looks to begin reopening, NIH continues to track how well our policies are meeting the evolving needs of the research community. In this post we would like to highlight allowance of preliminary data as a new special exception to our post submission materials policy and our guidance for reviewers.

Temporary, Emergency Situations Due to COVID-19 and Application Scores Received During Peer Review

As we continue to address the effects of the COVID-19 public health emergency on NIH-supported research, we are aware of applicant concerns about the potential impact of this temporary emergency situation on the outcome of peer review. We want to reassure applicants that we released guidance for reviewers that makes it clear that, when reviewing applications during the coronavirus pandemic national emergency, reviewers should assume that issues resulting from the coronavirus pandemic, such as the following, should not affect scores.

What happens if an institution has already submitted an application, and due to effects of COVID-19, some of the information needs to be revised?

Institutions affected by COVID-19 will be allowed to submit post-submission grant application materials to revise information that was submitted in an application as long as the materials are received at least fourteen days before the start of the review meeting. The post-submission grant application materials policy remains in effect. Only the types of materials allowed under the policy can be accepted. A letter of explanation (one page max.) is required.

Cyber Safety & COVID-19

The current outbreak of the novel coronavirus (COVID-19) has introduced new cybersecurity risks both at NIH and across the globe. As targeted phishing attacks prey on our desire to access trustworthy information and many of us make a shift toward remote work, we all need to be vigilant and take accountability for cyber safety. Here are some key tips to stay safe and avoid scams.

Roundup of New COVID-19 Resources for NIH Applicants and Recipients: Part 2

We continue to add new resources to our COVID-19: Information for NIH Applicants and Recipients of NIH Funding webpage. We hope they are helpful in helping you navigate this unprecedented situation. Here is a summary of what’s new since the last Nexus.

New NIH Resource to Analyze COVID-19 Literature: The COVID-19 Portfolio Tool

In the past few months, the scientific community has ramped up research in response to the SARS‑CoV‑2 pandemic; dozens of peer-reviewed articles and preprints on this topic are being added to the literature every day (Figure 1). This rapidly expanding effort has created challenges for scientists and the medical community who need to analyze thousands of scholarly articles for insights on the virus.